Follow The Filings

CVM Cel-Sci

Cel-Sci earnings company data as of 7:18 PM ET 8/21

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 14 Aug EPS — -0.47 —
Rev — — —

Insider trades

Open-market buys and sales by CVM's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CVM insider trades
  • $867K bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Geert R Kersten CEO
    Buy
    $138K 100,000 shares at $1.38 +46% to stake
    Traded Aug 25 Filed Aug 26
    ↗
  2. Geert R Kersten CEO
    Buy
    $360K 300,000 shares at $1.20 +2598% to stake
    Traded May 14 Filed May 18
    ↗
  3. Geert R Kersten CEO
    Buy
    $119K 100,000 shares at $1.19 +82% to stake
    Traded May 13 Filed May 14
    ↗
  4. Geert R Kersten CEO
    Buy
    $200K 38,023 shares at $5.26 +46% to stake
    Traded Jan 22 Filed Jan 26
    ↗
  5. Geert R Kersten CEO
    Buy
    $50K 8,389 shares at $5.96 +11% to stake
    Traded Dec 4, 2025 Filed Dec 5, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 12 stock grants.

SEC filings

Recent issuer filings from EDGAR, 15 shown.

Filed Form Detail Links
8-K 5.07 Filing Doc
10-Q FORM 10-Q Filing Doc
DEF 14A Filing Doc
8-K 1.01,8.01,9.01 Filing Doc
424B5 FORM 424B5 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 1.01,9.01 Filing Doc
424B4 Filing Doc
8-K 1.01,8.01,9.01 Filing Doc
S-1/A FORM S-1/A Filing Doc
S-1 FORM S-1 Filing Doc
10-Q FORM 10-Q Filing Doc
10-K FORM 10-K Filing Doc
8-K 3.03,9.01 Filing Doc
8-K 3.03,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.